These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Regulating human gene therapy: legislative overreaction to human subject protection failures. Leavitt WJ Adm Law Rev; 2001; 53(1):315-41. PubMed ID: 16189905 [No Abstract] [Full Text] [Related]
4. The future of clinical research. Levine RJ N Engl J Med; 1979 Dec; 301(23):1295-6. PubMed ID: 41181 [No Abstract] [Full Text] [Related]
5. The freedom of medical information. Brody EB JAMA; 1975 Jul; 233(2):145-6. PubMed ID: 1173440 [No Abstract] [Full Text] [Related]
6. Annual meeting of the New Clinical Drug Evaluation Units (NCDEU) program, Psychopharmacology Research Branch, National Institute of Mental Health, 23-25 May 1978, Key Biscayne, Florida. Psychopharmacol Bull; 1979 Jul; 15(3):22-44. PubMed ID: 493456 [No Abstract] [Full Text] [Related]
7. MBD, drug research and the schools. A Conference on Medical Responsibility and Community Control/February 13-14, 1976. Hastings Cent Rep; 1976 Jun; 6(3):suppl 1-23. PubMed ID: 955873 [No Abstract] [Full Text] [Related]
8. Protecting the "animal of necessity": limits to inquiry in clinical investigation. Swazey JP Daedalus; 1978; ():129-45. PubMed ID: 10236705 [No Abstract] [Full Text] [Related]
9. Who shall live? The tribulations of clinical trials. Small WE Am Pharm; 1979 May; 19(5):10-2. PubMed ID: 382813 [No Abstract] [Full Text] [Related]
10. Regulation of clinical research by the state. Grad FP Ann N Y Acad Sci; 1970 Jan; 169(2):533-45. PubMed ID: 4907502 [No Abstract] [Full Text] [Related]
11. Public regulation of recombinant dna gene therapy. McGarity TO; Shapiro SA J Leg Med; 1982 Jun; 3(2):185-210. PubMed ID: 6981676 [No Abstract] [Full Text] [Related]
12. Nontherapeutic research on children: an ethical dilemma. Lowe CU; Alexander D; Mishkin B J Pediatr; 1974 Apr; 84(4):468-73. PubMed ID: 4600567 [No Abstract] [Full Text] [Related]
13. Human experimentation, transplantation, and the law. Sadler AM; Sadler BL Ann N Y Acad Sci; 1970 Jan; 169(2):546-54. PubMed ID: 4907503 [No Abstract] [Full Text] [Related]
14. Making clinical trials safer for human subjects. Baram M Am J Law Med; 2001; 27(2-3):253-82. PubMed ID: 11467112 [No Abstract] [Full Text] [Related]
15. Protecting research subjects--what must be done. Shalala D N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573 [No Abstract] [Full Text] [Related]
16. Far beyond informed consent. US research institutions keep close watch on OPRR's suspensions. Russell-Einhorn M; Vaitukaitis J; Snyderman R; Rubenstein A; Abramson R; Hays M; Goodman L J Investig Med; 1999 Jul; 47(6):259-66. PubMed ID: 10431479 [No Abstract] [Full Text] [Related]
18. Duke's hazards. Did medical experiments put patients needlessly at risk? Kaplan S; Brownlee S US News World Rep; 1999 May; 126(20):66-8, 70. PubMed ID: 10387890 [No Abstract] [Full Text] [Related]
20. Recommendations of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research: impact on research in pharmacology. Introduction. Levine RJ Fed Proc; 1977 Sep; 36(10):2341-3. PubMed ID: 330250 [No Abstract] [Full Text] [Related] [Next] [New Search]